Navigation Links
WuXi AppTec Congratulates Chia Tai Tianqing Pharmaceutical Group and Janssen for Licensing Agreement
Date:1/8/2016

SHANGHAI, Jan. 8, 2016 /PRNewswire/ -- WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device industries, today congratulated Chia Tai Tianqing Pharmaceutical Group Co. Ltd. (CTTQ), a well-established Chinese pharmaceutical company that is a subsidiary of Sino Biopharmaceutical Ltd., and Janssen Pharmaceuticals Inc. (Janssen), a leading global pharmaceutical company, for having reached an exclusive license agreement. Under this agreement, CTTQ grants Janssen rights to develop and commercialize an undisclosed immuno-modulating agent to treat chronic hepatitis B virus (HBV) infection globally outside China. Both CTTQ and Janssen are long-time collaboration partners of WuXi. In 2013, CTTQ signed a contract with WuXi to discover anti-HBV small-molecule drugs. WuXi provided end-to-end integrated research services on the compound that is the subject of this license agreement.

Hepatitis B is a serious and potentially fatal infectious disease afflicting more than 350 million patients worldwide. China has the world's largest hepatitis B patient population. Currently there is no cure for the disease, and effective new drugs are urgently needed.

"We congratulate CTTQ and Janssen on this important agreement," said Dr. Ge Li, Chairman and CEO of WuXi AppTec. "WuXi is proud to have played a part in this collaboration to bring an innovative drug candidate closer to hepatitis B patients in China and around the world."

About WuXi AppTec

WuXi AppTec is a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States. As a research-driven and customer-focused company, WuXi provides pharmaceutical, biotechnology, and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi is also building a platform to provide clinical diagnostic services directly to physicians and their patients globally. WuXi's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D.

For more information, please contact:
Aaron Shi
Director of Corporate Communications
+86-21 5046-4362
aaron_shi@wuxiapptec.com


'/>"/>
SOURCE WuXi AppTec
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. WuXi AppTec Denies Issuing Press Release Regarding Great Basin Scientific
2. Med Data Quest Tackles Oncology Informatics Challenges with WuXi AppTec
3. Nobel Prize Laureate Professor Barry Sharpless Visits WuXi AppTec Headquarters in Shanghai
4. WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax
5. WuXi AppTec Successfully Completes Its First 2000L Disposable Bioreactor Run Using an NS0 Cell Line, Marking an Industry Milestone
6. National Photonics Initiative Congratulates Industry Partner Hamamatsu on Contributions to Nobel Prize-Winning Research
7. North American Cannabis Holdings Congratulates JV Partner NaturesComfortMeds on Award of Two US Patents
8. OTC Markets Group Congratulates Aethlon Medical on NASDAQ Listing
9. OTC Markets Group Congratulates OncoSec Medical on NASDAQ Listing
10. Kids v Cancer Congratulates United Therapeutics on Receiving Priority Review Voucher Through the Creating Hope Act
11. WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2018)... ... December 14, 2018 , ... Drs. Mario J. Canal and ... with loose dentures in the Cherry Hill, NJ area to find out ... to replace the look and most functions of missing teeth, All-on-4 dental implants have ...
(Date:12/14/2018)... , ... December 14, 2018 , ... ... the 2018 edition of the "112 hospital and health system physician leaders to ... presidents, CEOs, C-suite executives and leaders who also hold medical degrees. These individuals ...
(Date:12/13/2018)... ... December 14, 2018 , ... ... wellness experience resort-wide, The Ritz-Carlton, Amelia Island will expand its platforms emphasizing ... experts in yoga, meditation, fitness and nutrition; innovative spa treatments; regularly offered ...
Breaking Medicine Technology:
(Date:12/14/2018)... Md. (PRWEB) , ... December 14, 2018 , ... The ... for the term beginning January 1, 2019. In the fall of 2018, PDA’s 10,500 ... The following candidates have been elected/appointed as Directors to the PDA Board of Directors ...
(Date:12/13/2018)... ... 2018 , ... Cantata Health, a leading provider of software ... enhancements to its NetSolutions™ platform. The new features and partnerships allow LTC providers ... time. , Enhancements made to EHR and Financial Management modules on the ...
(Date:12/13/2018)... ... December 13, 2018 , ... Shady Grove Fertility (SGF) ... medical team, seeing patients at SGF’s Woodbridge, VA location. Dr. Swelstad ... and treatment options for female and male infertility, as well as elective fertility ...
(Date:12/13/2018)... ... December 13, 2018 , ... ... Schools , As part of its commitment to providing more jobs in America, ... Fellow Health Partners, Inc., a New York based medical business solutions company, today ...
(Date:12/13/2018)... LOS ANGELES (PRWEB) , ... December 13, 2018 , ... ... advantage of the opportunity to win a full-ride scholarship offered by Dr. Kami Hoss ... Academy is Dec. 17. The full-ride scholarship would enable a student to become a ...
Breaking Medicine News(10 mins):